PT - JOURNAL ARTICLE AU - LIMING WANG AU - YASUMITSU HIRANO AU - GREGORY HENG AU - TOSHIMASA ISHII AU - HIROKA KONDO AU - KIYOKA HARA AU - NAO OBARA AU - MASAHIRO ASARI AU - SHIGEKI YAMAGUCHI TI - Prognostic Utility of Apical Lymph Node Metastasis in Patients With Left-sided Colorectal Cancer AID - 10.21873/invivo.12129 DP - 2020 Sep 01 TA - In Vivo PG - 2981--2989 VI - 34 IP - 5 4099 - http://iv.iiarjournals.org/content/34/5/2981.short 4100 - http://iv.iiarjournals.org/content/34/5/2981.full SO - In Vivo2020 Sep 01; 34 AB - Background: Unlike the tumor nodes metastasis (TNM) lymph node classification, based solely on counts of nodal metastases, the Japanese system of classifying colorectal carcinoma (CRC) focuses on regional lymph node spread. In this study, we explored the prognostic utility of inferior mesenteric artery (IMA) apical lymph node (APN) metastasis. Patients and Methods: This was a retrospective study of patients with stage III left-sided CRC. All enrollees were subjected to D3 resection between April 2007 and December 2016 at the International Medical Center of Saitama Medical University and then stratified by histologic presence (APN+ group) or absence (APN− group) of tumor in APNs examined postoperatively. Ultimately, propensity score matching was invoked (1:2) and COX regression analysis was conducted, determining group rates of relapse-free survival (RFS) and cancer-specific survival (CSS). Results: A total of 498 patients were studied, grouped as APN+ (19/498, 3.8%) or APN− (479/498, 96.2%). Prior to matching, the APN+ (vs. APN−) group showed significantly more lymphatic involvement (73.7% vs. 47.8%; p=0.023), deep (T3/T4) tumor infiltration (100% vs. 78.9%; p=0.024), and nodal metastasis (N2: 84.2% vs. 27.6%; p<0.001). In addition, para-aortic nodal recurrences were significantly increased (15.7% vs. 2.0%; p<0.001), conferring worse RFS (p<0.001) and CSS (p=0.014) rates. Once baseline factors were matched, the two groups appeared similar in RFS (p=0.415) and CSS (p=0.649). Multivariate regression analysis indicated that elevated carcinoembryonic antigen (CEA) level and deep tumor infiltration were independent risk factors for RFS, whereas postoperative complications and tumor-positive node counts were independent risk factors for CSS. APN+ status was not a significant risk factor for RFS or CSS. Conclusion: APN positivity may thus constitute a regional rather than systemic manifestation. The TNM staging based on the number of metastatic lymph nodes seems to be more reasonable than the regional lymph node classification method.